
Enzon Pharmaceuticals rose 10775.0% from $0.04 to $4.35, ahead of the S&P 500's +4.7%. Its worst day was Jan 5 (−95.9%), and its low came Dec 1 at $0.04.
Nov 21, 2025 – Jul 22, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Enzon Pharmaceuticals closed at its lowest level of the year, 6.0% below where the year started.
−1.1%
Enzon Pharmaceuticals shares rose 1873.1%, while the S&P 500 rose 0.2%.
+1873.1% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
Enzon Pharmaceuticals shares rose 1782.1%, while the S&P 500 rose 0.6%.
+1782.1% · S&P 500 +0.6%
Enzon Pharmaceuticals shares rose 2480.6%, while the S&P 500 fell 0.1%.
+2480.6%, the year's best day · S&P 500 −0.1%
Enzon Pharmaceuticals shares rose 2122.2%, while the S&P 500 rose 0.2%.
+2122.2% · S&P 500 +0.2%
EPS of $-2.00 was reported on $0.00 revenue.
+4.1% · S&P 500 −0.9%
Enzon Pharmaceuticals shares rose 1350.0%, while the S&P 500 rose 2.9%.
+1350.0% · S&P 500 +2.9%
Enzon Pharmaceuticals closed at its highest level of the year, 19400.0% above where the year started.
+1.3% · S&P 500 +1.0%
EPS of $-0.84 was reported on $86.5M revenue.
−11.4% · S&P 500 +0.8%
Where it ended: a close of $4.35 on Jul 22, 2026. Up next: Q3 2026 earnings on Dec 4, 2026.
Nothing in the past 12 months.
All ENZN analyst actionsNothing in the past 12 months.
All ENZN dividend history